Hosted on MSN11mon
Vaccines are a glimmer of hope against malaria, but the battle has only just begunStoring vaccines at the right temperature can also be a substantial logistical challenge, making the thermostability of R21 a real benefit. Overcoming these barriers requires innovative solutions ...
“It is potentially a more targeted and efficient way of delivering vaccines,” says Munro. Vaxxas’ high-density microarray patch (HD-MAP) technology also has thermostability benefits that ...
Meanwhile, Peer has also focused on improving nanoparticle thermostability. An obstacle to the widespread delivery of LNP-mRNA COVID-19 vaccines is the need to keep them stored at very low ...
Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its high-density microarray patch ...
The agreement, worth $4.3 million, is the first to be announced as part of CEPI’s call in January 2022 for proposals aimed at improving thermostability of a variety of new vaccine platforms ...
where the company received approval to advance a CEPI-funded program following promising proof-of-concept results showing excellent thermostability and effective delivery of an mRNA vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results